Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Botella Estrada

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Actas Dermo-Sifiliograficas|October 15, 2020
Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm RegistryD P Ruiz-Genao, G Carretero, R Rivera, et al.
The British Journal of Dermatology|May 26, 2019
Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) show more than a 50% reduction in age-adjusted fertility rate when compared with the general populationA Gonzalez-Cantero, G Carretero, R Rivera, et al.
Actas Dermo-Sifiliograficas|April 16, 2022
Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry ExperienceL M Nieto Benito, G Carretero, R Rivera-Díaz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 1, 2021
Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma RegistryA Sánchez-Velázquez, A Bauer-Alonso, T Estrach, et al.
Actas Dermo-Sifiliograficas|February 7, 2024
[Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)C Couselo-Rodríguez, A Batalla, J M Carrascosa, et al.
Actas Dermo-Sifiliograficas|July 23, 2023
Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)C Couselo-Rodríguez, A Batalla, J M Carrascosa, et al.
Actas Dermo-Sifiliograficas|May 12, 2023
[Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early FindingsM Munera-Campos, P Chicharro, A Gonzalez Quesada, et al.
Actas Dermo-Sifiliograficas|March 19, 2023
BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early FindingsM Munera-Campos, P Chicharro, A Gonzalez Quesada, et al.
Actas Dermo-Sifiliograficas|December 7, 2025
Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort StudyM Mansilla-Polo, M Pons-Benavent, P Fernández-Crehuet, et al.
Actas Dermo-Sifiliograficas|December 18, 2022
Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 YearsD Falkenhain-López, C Muniesa, M T Estrach, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Actas Dermo-Sifiliograficas|October 15, 2020
Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm RegistryD P Ruiz-Genao, G Carretero, R Rivera, et al.
The British Journal of Dermatology|May 26, 2019
Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) show more than a 50% reduction in age-adjusted fertility rate when compared with the general populationA Gonzalez-Cantero, G Carretero, R Rivera, et al.
Actas Dermo-Sifiliograficas|April 16, 2022
Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry ExperienceL M Nieto Benito, G Carretero, R Rivera-Díaz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 1, 2021
Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma RegistryA Sánchez-Velázquez, A Bauer-Alonso, T Estrach, et al.
Actas Dermo-Sifiliograficas|February 7, 2024
[Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)C Couselo-Rodríguez, A Batalla, J M Carrascosa, et al.
Actas Dermo-Sifiliograficas|July 23, 2023
Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)C Couselo-Rodríguez, A Batalla, J M Carrascosa, et al.
Actas Dermo-Sifiliograficas|May 12, 2023
[Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early FindingsM Munera-Campos, P Chicharro, A Gonzalez Quesada, et al.
Actas Dermo-Sifiliograficas|March 19, 2023
BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early FindingsM Munera-Campos, P Chicharro, A Gonzalez Quesada, et al.
Actas Dermo-Sifiliograficas|December 7, 2025
Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort StudyM Mansilla-Polo, M Pons-Benavent, P Fernández-Crehuet, et al.
Actas Dermo-Sifiliograficas|December 18, 2022
Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 YearsD Falkenhain-López, C Muniesa, M T Estrach, et al.
Pageof 15